Vaccine

Professor Michael Baker has been a constant and reassuring presence on Sunday Morning throughout the Covid-19 lockdown period. He returns to answer your questions and ours about the pandemic and the… Audio

Professor Johan Giesecke is one of the world's most senior epidemiologists. He believes lockdowns like the one we've just had in New Zealand are just a way of delaying the inevitable. Professor… Audio

Gary McLean is a professor in molecular immunology at London Metropolitan University who specialises in infectious diseases, immunology and antibody engineering. He discusses the big international… Audio

A vaccine for Covid-19 could be developed in the next 18 months, but it could be longer depending on how the virus mutates, the head of the Human Vaccines Project says Audio

In early March fellow journalists were bemused by Donald McNeil's glove wearing and surface-sanitising ways. The New York Times' health and science reporter saw the pandemic coming and took personal… Audio

Do you become immune after SARS-CoV-2 infection? And if so, how long does that immunity last? Helen Stillwell from  Yale University has been looking at the question of what role immunity will play in… Audio

Gary McLean is a professor in molecular immunology at London Metropolitan University who specialises in infectious diseases, immunology and antibody engineering. He joins the show to look at the big… Audio

Medicines New Zealand says a health ministry statement on Nine to Noon was the first it heard about the government's plans to bring together 'the key players in a coordinated approach' on a national… Audio

Infectious disease experts say the government must develop a national vaccine strategy, and someone to lead it. It comes as fears mount that New Zealand could be at the back of the queue for a… Audio

While the world races to find a vaccine against Covid 19, Professor David Murdoch an international expert in infectious disease from the University of Otago cautions it is possibly a year and a half… Audio

We're still hearing about patient trials of the Remdesivir and Hydroxychloroquine for treatment of Covid-19 patients, but Nobel Prize-winning professor Peter Doherty says neither option is shaping as… Audio

Vaccinologist and Auckland University Associate Professor, Dr Helen Petousis-Harris says there's a big knowledge gap for parents about their children's vaccination status. Audio

Wallace Chapman speaks to Associate Professor James Ussher, Director of the Webster Centre for Infectious Diseases ahead of the human trials in the UK for a potential vaccine to coronavirus. Audio

Superman and his descendants launched a fascination with technological superism that continues today. Iwan Rhys Morus is professor of history at Aberystwyth University in Wales and has recently… Audio

CSIRO, Australia's national science agency, has begun the first stage of testing vaccine candidates for COVID-19, in what it's calling a 'critical research milestone'. Australian Animal Health… Audio

Remdesivir is being billed as the most promising Covid-19 drug by researchers. Andrew Joseph is a reporter at STAT covering health and medicine who has been looking into Remdesivir.  Audio

Nobel prize-winning Australian immunologist Professor Peter Doherty says need to think like we’ve already got Covid-19 if we want to protect our most vulnerable. Audio

Kiwi Gary McLean is a Professor of Immunology at the London Metropolitan University. His recent research has been looking at developing a possible inoculation for the common cold - something that has… Audio

Sara Del Valle is an applied mathematician and disease modeller. She and other disease modellers have gazed into their computers to see the future of Covid-19 and the news, in her opinion, is not bad… Audio

Professor Chris Lowry from Colorado University is part of a team of scientists who have uncovered a bacteria found in soil which can help combat anxiety and depression.  Audio